Cardinal Health CFO sells 42K shares at ~$235

Q: What insider transaction did CAH report for CFO Aaron E. Alt on August 18, 2026?

CARDINAL HEALTH INC reported that CFO Aaron E. Alt sold 42,000 Common Shares of CAH on August 18, 2026. The shares were sold in four open-market or private transaction blocks at weighted average prices between about $234.55 and $237.26.

Q: At what prices were Aaron E. Alt’s CAH shares sold in the August 18, 2026 Form 4?

The Form 4 shows weighted average prices of $234.55, $235.54, $236.58, and $237.26 per CAH share. Footnotes state each block reflects multiple trades within specific price ranges between $234.07 and $237.67.

Q: How many CAH shares did the CFO sell in each block reported on August 18, 2026?

Aaron E. Alt sold 3,115, 12,228, 13,685, and 12,972 CAH Common Shares in four separate blocks. In total, the Form 4 transaction summary reports 42,000 shares sold across these open-market or private transactions.

Q: Were the CAH insider sales by CFO Aaron Alt single trades or multiple transactions per price?

Each reported price per share is a weighted average price for multiple transactions. Footnotes explain that every block’s sales were executed through numerous trades within specified price ranges, rather than single trades at one exact price.

Q: Does the August 18, 2026 CAH Form 4 indicate use of a Rule 10b5-1 trading plan?

The filing’s 10b5-1 status box is not checked, and the provided footnotes do not state that a plan applied. The disclosure describes the transactions simply as sales in open market or private transactions without referencing a trading plan.

CARDINAL HEALTH INC (CAH) reported that Chief Financial Officer Aaron E. Alt sold a total of 42,000 Common Shares on August 18, 2026 in open-market or private transactions.

Filing Impact

(Neutral)

Filing Sentiment

(Very Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

CARDINAL HEALTH INC (CAH) reported that Chief Financial Officer Aaron E. Alt sold a total of 42,000 Common Shares on August 18, 2026 in open-market or private transactions. The sales were executed in four blocks at weighted average prices between $234.55 and $237.26, with each price representing a weighted average of multiple trades within stated intraday ranges.

Insider Trade Summary

Net Seller: 42,000 shares

Net Sell 4 txns

Insider Alt Aaron E

Role Chief Financial Officer

Sold 42,000 shs ($9.93M)

Type	Security	Shares	Price	Value
Sale	Common Shares ^F1	3,115	$234.55	$731K
Sale	Common Shares ^F2	12,228	$235.54	$2.88M
Sale	Common Shares ^F3	13,685	$236.58	$3.24M
Sale	Common Shares ^F4	12,972	$237.26	$3.08M

Holdings After Transaction: Common Shares — 20,495 shares (Direct)

Footnotes (4)

F1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $234.99, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, 3, and 4 to this Form 4.
F2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.08 to $236.07, inclusive.
F3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.095 to $237.08, inclusive.
F4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.095 to $237.67, inclusive.

Key Figures

Total shares sold: 42,000 shares Block 1 sale: 3,115 shares at $234.55 Block 2 sale: 12,228 shares at $235.54 +2 more

5 metrics

Total shares sold 42,000 shares Aggregate Common Shares sold by CFO Aaron E. Alt on 2026-08-18

Block 1 sale 3,115 shares at $234.55 Weighted average price; trades ranged from $234.07 to $234.99

Block 2 sale 12,228 shares at $235.54 Weighted average price; trades ranged from $235.08 to $236.07

Block 3 sale 13,685 shares at $236.58 Weighted average price; trades ranged from $236.095 to $237.08

Block 4 sale 12,972 shares at $237.26 Weighted average price; trades ranged from $237.095 to $237.67

Key Terms

weighted average price, open market or private transaction, Common Shares

3 terms

weighted average price financial

"The price reported in column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

Common Shares financial

"security_title: Common Shares"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CAH report for CFO Aaron E. Alt on August 18, 2026?

CARDINAL HEALTH INC reported that CFO Aaron E. Alt sold 42,000 Common Shares of CAH on August 18, 2026. The shares were sold in four open-market or private transaction blocks at weighted average prices between about $234.55 and $237.26.

At what prices were Aaron E. Alt’s CAH shares sold in the August 18, 2026 Form 4?

The Form 4 shows weighted average prices of $234.55, $235.54, $236.58, and $237.26 per CAH share. Footnotes state each block reflects multiple trades within specific price ranges between $234.07 and $237.67.

How many CAH shares did the CFO sell in each block reported on August 18, 2026?

Aaron E. Alt sold 3,115, 12,228, 13,685, and 12,972 CAH Common Shares in four separate blocks. In total, the Form 4 transaction summary reports 42,000 shares sold across these open-market or private transactions.

Were the CAH insider sales by CFO Aaron Alt single trades or multiple transactions per price?

Each reported price per share is a weighted average price for multiple transactions. Footnotes explain that every block’s sales were executed through numerous trades within specified price ranges, rather than single trades at one exact price.

Does the August 18, 2026 CAH Form 4 indicate use of a Rule 10b5-1 trading plan?

The filing’s 10b5-1 status box is not checked, and the provided footnotes do not state that a plan applied. The disclosure describes the transactions simply as sales in open market or private transactions without referencing a trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/20/2026 - 07:29 AM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alt Aaron E

(Last)

(First)

(Middle)

7000 CARDINAL PLACE

(Street)

DUBLIN

OHIO

43017

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARDINAL HEALTH INC [ CAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	08/18/2026		S		3,115	D	$234.55⁽¹⁾	59,380	D
Common Shares	08/18/2026		S		12,228	D	$235.54⁽²⁾	47,152	D
Common Shares	08/18/2026		S		13,685	D	$236.58⁽³⁾	33,467	D
Common Shares	08/18/2026		S		12,972	D	$237.26⁽⁴⁾	20,495	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.07 to $234.99, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 1, 2, 3, and 4 to this Form 4.

2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.08 to $236.07, inclusive.

3. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.095 to $237.08, inclusive.

4. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.095 to $237.67, inclusive.

Remarks:

	/s/ Amanda S. Pashi, Attorney-in-fact	08/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR